We are proud to announce that all participants have received the third and final vaccination dose in our large randomized, placebo-controlled, and double-blind phase IIb study in The Gambia. The study started in 2021 and is part of the late phase development program in Africa for Scandinavian Biopharma’s vaccine candidate, ETVAX®, against Enterotoxigenic Escherichia coli […]
Scandinavian Biopharma continue to strengthen the organization in regulatory affairs through the recruitment of Marja Held as the new Senior Regulatory Affairs Manager. Marja has Master of Science in Pharmacy from Uppsala University, and she has an extensive experience in Regulatory Affairs from various pharmaceutical companies both small-size and larger enterprises. She most recently came […]
Scandinavian Biopharma continues to strengthen its organization in manufacturing and is pleased to welcome Anna Sumic as our new DS & DP Manufacturing Specialist. Anna has a Master of Science in Chemistry and Chemical Engineering from KTH, Royal Institute of Technology, with 15 years of experience within the pharmaceutical industry. She is joining us from […]
Join us when we are expanding our unit with another Clinical Project Manager. In this role, you will lead the planning, execution and documentation of clinical studies for our late clinical phase vaccine products. Join us in our work to give people worldwide a longer and better life. We are an entrepreneurial company and experts […]
We are proud to partner with Bio Products Laboratory (BPL) in recognizing the Hereditary Factor X (10) Deficiency Awareness Day on October 10, 2022. This is a day to encourage education and awareness around a very rare bleeding disorder – Hereditary Factor X Deficiency. About one in a million people have Hereditary Factor X Deficiency, […]
We are delighted to be highlighted in the Annual Report from EDCTP (European & Developing Countries Clinical Trials Partnership). ETEC Vaccine Efficacy – EDCTP Annual Report
